Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Linda Ø, Henriksen"'
Autor:
Willemijn J. Comuth, Moniek P.M. de Maat, Linda Ø Henriksen, Anna-Marie Bloch Münster, Daan van de Kerkhof, Steen Dalby Kristensen, Steen Elkjær Husted
Publikováno v:
Comuth, W J, Henriksen, L Ø, van de Kerkhof, D, Husted, S E, Kristensen, S D, de Maat, M P M & Münster, A-M B 2018, ' Comprehensive characteristics of the anticoagulant activity of dabigatran in relation to its plasma concentration ', Thrombosis Research, vol. 164, pp. 32-39 . https://doi.org/10.1016/j.thromres.2018.02.141
Thrombosis Research, 164, 32-39. Elsevier Ltd.
Thrombosis Research, 164, 32-39. Elsevier
Thrombosis Research, 164, 32-39. Elsevier Ltd.
Thrombosis Research, 164, 32-39. Elsevier
BACKGROUND: Issues with laboratory measurement of dabigatran include: 1. Do coagulation assays reflect dabigatran plasma concentrations? 2. Do samples from patients treated with dabigatran have the same coagulability as dabigatran-spiked samples from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dec6e35699240bc6f7740f5c7cbd78d9
https://findresearcher.sdu.dk:8443/ws/files/141556232/Comprehensive_characteristics_of_the_anticoagulant_activity_of_dabigatran_in_relation_to_its_plasma_concentration.pdf
https://findresearcher.sdu.dk:8443/ws/files/141556232/Comprehensive_characteristics_of_the_anticoagulant_activity_of_dabigatran_in_relation_to_its_plasma_concentration.pdf
Publikováno v:
Comuth, W J, Faaborg, L, Henriksen, L Ø & Münster, A-M B 2018, ' Measurement of dabigatran : previously demonstrated Hemoclot® Thrombin Inhibitor assay reagent instability on Sysmex CS-2100i is no longer an issue ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 78, no. 1-2, pp. 149-152 . https://doi.org/10.1080/00365513.2017.1403037
Comuth, W, Faaborg, L, Henriksen, L Ø & Münster, A-M B 2017, ' Measurement of dabigatran: previously demonstrated Hemoclot® Thrombin Inhibitor assay reagent instability on Sysmex CS-2100i is no longer an issue ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 78, no. 1-2, pp. 149-152 . https://doi.org/10.1080/00365513.2017.1403037
Comuth, W, Faaborg, L, Henriksen, L Ø & Münster, A-M B 2017, ' Measurement of dabigatran: previously demonstrated Hemoclot® Thrombin Inhibitor assay reagent instability on Sysmex CS-2100i is no longer an issue ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 78, no. 1-2, pp. 149-152 . https://doi.org/10.1080/00365513.2017.1403037
The Hemoclot® Thrombin Inhibitor (HTI) assay has been recommended for measurement of dabigatran concentrations in specific clinical situations. Traditionally, reagents for biochemical assays are prepared from instructions found in the package insert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d15a5e64d88f8147b0ad9ede8d8c836
https://portal.findresearcher.sdu.dk/da/publications/1d5efdf6-baa0-46bf-8183-53bd182585f6
https://portal.findresearcher.sdu.dk/da/publications/1d5efdf6-baa0-46bf-8183-53bd182585f6
Autor:
Willemijn J. Comuth, Linda Ø Henriksen, Jerzy Malczynski, Anna-Marie Bloch Münster, Anne-Mette Haase, Daan van de Kerkhof
Publikováno v:
Comuth, W J, Haase, A-M, Henriksen, L Ø, Malczynski, J, van de Kerkhof, D & Münster, A-M B 2018, ' Cholestatic liver injury as a side-effect of dabigatran and the use of coagulation tests in dabigatran intoxication and after reversal by idarucizumab in bleeding and sepsis ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 78, no. 1-2, pp. 1-5 . https://doi.org/10.1080/00365513.2017.1402127
Scandinavian Journal of Clinical and Laboratory Investigation, 78(1-2), 1-5. Informa Healthcare
Scandinavian Journal of Clinical and Laboratory Investigation, 78(1-2), 1-5. Informa Healthcare
Idarucizumab, an antidote specific for dabigatran, became available recently. Dabigatran is not associated with increased risk of hepatotoxicity in comparison with warfarin, but it is seen as a rare side-effect. Cases of cholestatic liver injury due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f2b7f57c45795baba2741ebf0aea37e
https://portal.findresearcher.sdu.dk/da/publications/5c745c7b-e3cb-4a53-b5ff-21fb4d36e8e2
https://portal.findresearcher.sdu.dk/da/publications/5c745c7b-e3cb-4a53-b5ff-21fb4d36e8e2
Publikováno v:
Scandinavian journal of clinical and laboratory investigation. 78(1-2)
The Hemoclot
Publikováno v:
Henriksen, L O, Faber, N R, Moller, M F, Nexo, E & Hansen, A B 2014, ' Stability of 35 biochemical and immunological routine tests after 10 hours storage and transport of human whole blood at 21°C ', Scandinavian journal of clinical and laboratory investigation, vol. 74, no. 7, pp. 603-10 . https://doi.org/10.3109/00365513.2014.928940
Scandinavian Journal of Clinical and Laboratory Investigation
Scandinavian Journal of Clinical and Laboratory Investigation
BACKGROUND: Suitable procedures for transport of blood samples from general practitioners to hospital laboratories are requested. Here we explore routine testing on samples stored and transported as whole blood in lithium-heparin or serum tubes. METH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9351acc0df42405b092546d7f9ac0ba
https://pure.au.dk/portal/da/publications/stability-of-35-biochemical-and-immunological-routine-tests-after-10-hours-storage-and-transport-of-human-whole-blood-at-21c(2b1f9999-070c-49e3-89f3-1a52b58071b7).html
https://pure.au.dk/portal/da/publications/stability-of-35-biochemical-and-immunological-routine-tests-after-10-hours-storage-and-transport-of-human-whole-blood-at-21c(2b1f9999-070c-49e3-89f3-1a52b58071b7).html
Publikováno v:
Skin Pharmacology and Physiology. 10:12-20
Analogues of vitamin D3 have recently been introduced for the topical treatment of psoriasis. Their therapeutic effects are thought to be mediated by interaction with the vitamin D3 receptor (VDR) in epidermal keratinocytes (KCs). The purpose of the
Publikováno v:
Biochemical pharmacology. 55(6)
The biological active form of vitamin D, 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 ), mediates most of its actions through the intracellular vitamin D receptor (VDR). VDR binds to vitamin D responsive elements (VDREs) in the promoter region of respon
Autor:
Søren Neve, Kirsten K Jakobsen, Lene Aarenstrup, Linda Ø Henriksen, Anne-Marie Falch, Karsten Kristiansen, Niels Tommerup, Henrik Leffers
Publikováno v:
ResearcherID
4-hydroxyphenylpyruvate dioxygenase (HPD) (EC 1.13.11.27) is a key enzyme involved in tyrosine catabolism. Congenital HPD deficiency is a rare, relatively benign condition known as hereditary type III tyrosinemia. The severe type I tyrosinemia, cause
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d4ea7a9af566cea225b8fd8869ccf14
https://www.ncbi.nlm.nih.gov/pubmed/12127941
https://www.ncbi.nlm.nih.gov/pubmed/12127941